about
Aspirin intake and survival after breast cancerAspirin and breast cancer prevention--a link to ER statusAssociation between frequent use of nonsteroidal anti-inflammatory drugs and breast cancerA Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersExemestane for breast cancer prevention: a critical shift?Breast cancer chemoprevention: old and new approachesNon steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityProstate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysisEvidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosisRisk of breast cancer among users of aspirin and other anti-inflammatory drugsDo nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysisCOX inhibitors and breast cancerA population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirinAssociation of regular aspirin use and breast cancer riskGenetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer riskThe National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trialInflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancerNSAIDs and breast cancer recurrence in a prospective cohort studyUse of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control studyAlleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory DrugsCytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth.Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.Minireview: Obesity and breast cancer: a tale of inflammation and dysregulated metabolismCritical Overview on the Benefits and Harms of Aspirin.The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer.Analgesic use and sex steroid hormone concentrations in postmenopausal women.Prevention of ER-negative breast cancerNon-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study.Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyEffect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells.Participating in primary care research.Breast cancer prevention.Repression of beta-catenin function in malignant cells by nonsteroidal antiinflammatory drugsProstate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer riskConcept of chemoprevention in colorectal cancer.Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplificationCurrent concepts in cyclooxygenase inhibition in breast cancer.Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.
P2860
Q24604280-E2F37EED-A105-48AB-88E6-267613E62CC7Q24806520-03028AEF-C21C-4A0E-9809-2431357BBBA6Q25257496-1754B53D-6C64-407F-AE1F-202D7BB39F47Q26739665-60FECC55-0365-4856-840D-0F1395BBA501Q27028211-6E4B4560-E3C5-462D-8AB4-2D44E249B8D6Q27693259-1AA79AE0-03A6-48A8-A72C-096D55E05604Q28166312-B4AE5011-BE73-4A44-9E56-9EAE1B1A4159Q28166676-7005B6C8-DAE4-449D-83AD-DFA185F0BE66Q28168893-5DECCB33-8392-4C8F-B0EA-B38622D86EE6Q28169157-33EE0390-2301-413D-99EC-CEE395C1E1D5Q28185207-53B0BE3F-8175-4559-BE19-81F43DD1D13CQ28194592-8337678D-B002-4A5D-B8FD-0EE9E0FA4375Q28195221-563C519F-8775-4B19-8261-FB5FC1FF80D7Q28211831-8CD8009B-E1EA-4539-B10B-80F93E5221B6Q28213217-57EB91F8-FDF5-4C57-B1CF-7A118865DA18Q28217652-244B7A2F-0484-49FC-AAE7-6E6D8318A871Q28218639-BE4EAA93-04D0-49C3-8963-3A624D6A070FQ28221965-DE781D13-D812-4129-8815-65E6006DBF8FQ28476849-E8C32177-D58F-49A6-BD72-4D3610C3D36EQ30234292-3F0B944B-DC50-4B3F-AE7F-426D92F5CF30Q30352693-190554BC-548E-410F-B77A-16BD0E10F669Q33195488-A1E9D215-03B6-4605-8284-E3338C73A038Q33635798-6006154D-4F2B-4BA8-9530-EA33333449B1Q33664298-5624AC78-F3EF-4060-8DEA-B9C893D15F00Q33664316-0A76A67E-55D5-4D04-AF2E-418DDFC53F69Q33780860-856B218D-5287-41D0-A609-AAE76B679875Q33796968-3E7727E1-0A90-4C4F-B5EA-DD5DBB942C8CQ33834355-AB740C30-D0FB-4D43-B71D-4E2CAF74B3B5Q33889458-B2007967-EEFB-499A-9364-8EBF5EF46DC3Q34141566-5A313305-7721-41A2-B6BF-D2E8B2003A65Q34222783-FF55934F-EF85-480D-92D1-C2E73A7C8650Q34222791-62D5F153-112F-4230-B198-E2927A25D5D4Q34234828-7A22D598-62B9-4D08-9284-8146B2F99C66Q34283636-A6CB8303-E88C-4E42-AB93-45F69B01545EQ34325928-ACB64B73-8FB0-4953-A297-B06990E32E27Q34390842-96C00309-E92D-4371-809F-F7604C8B3E9BQ34458235-81493621-76A6-49D1-A970-C5003C20AAA6Q34913841-C599EA7D-16EE-4848-9F15-CFE4C3D9963BQ34969789-BB6D27AA-93BC-42B6-B2C1-5FEC1221824BQ35227086-E29FF8E2-7EBD-4C40-8E13-2F3B6923AC2B
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Breast cancer and NSAID use: a meta-analysis
@ast
Breast cancer and NSAID use: a meta-analysis
@en
type
label
Breast cancer and NSAID use: a meta-analysis
@ast
Breast cancer and NSAID use: a meta-analysis
@en
prefLabel
Breast cancer and NSAID use: a meta-analysis
@ast
Breast cancer and NSAID use: a meta-analysis
@en
P2860
P356
P1476
Breast cancer and NSAID use: a meta-analysis
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2000.1709
P407
P577
2001-05-01T00:00:00Z
P5875
P6179
1043809990